The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300
Abstract
An isolate of the methicillin-resistant Staphylococcus aureus (MRSA) clone USA300 with reduced susceptibility to vancomycin (SG-R) (i.e, vancomycin-intermediate S. aureus, VISA) and its susceptible "parental" strain (SG-S) were recovered from a patient at the end and at the beginning of an unsuccessful vancomycin therapy. The VISA phenotype was unstable in vitro generating a susceptible revertant strain (SG-rev). The availability of these 3 isogenic strains allowed us to explore genetic correlates of antibiotic resistance as it emerged in vivo. Compared to the susceptible isolate, both the VISA and revertant strains carried the same point mutations in yycH, vraG, yvqF and lspA genes and a substantial deletion within an intergenic region. The revertant strain carried a single additional frameshift mutation in vraS which is part of two component regulatory system VraSR. VISA isolate SG-R showed complex alterations in phenotype: decreased susceptibility to other antibiotics, slow autolysis, abnormal cell division and increased thickness of cell wall. There was also altered expression of 239 genes including down-regulation of major virulence determinants. All phenotypic properties and gene expression profile returned to parental levels in the revertant strain. Introduction of wild type yvqF on a multicopy plasmid into the VISA strain caused loss of resistance along with loss of all the associated phenotypic changes. Introduction of the wild type vraSR into the revertant strain caused recovery of VISA type resistance. The yvqF/vraSR operon seems to function as an on/off switch: mutation in yvqF in strain SG-R turns on the vraSR system, which leads to increase in vancomycin resistance and down-regulation of virulence determinants. Mutation in vraS in the revertant strain turns off this regulatory system accompanied by loss of resistance and normal expression of virulence genes. Down-regulation of virulence genes may provide VISA strains with a "stealth" strategy to evade detection by the host immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, VISA strains may serve as precursors to the eventual emergence of fully resistant VRSA strains, emphasizing the need for continuous surveillance and novel treatment strategies [216,219,220,221].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., Chambers, H. F., Lu, Y., & Otto, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900743106 · Cited by 394
Self-citation
Research works printed but not linked: 66
- SK Pillai, 2009, Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus., Clin Infect Dis, 49, 1169, 10.1086/605636 · DOI
- K Hiramatsu, 1997, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin., Lancet, 350, 1670, 10.1016/S0140-6736(97)07324-8 · DOI · Paper page
- TL Smith, 1999, Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus Working Group., N Engl J Med, 340, 493, 10.1056/NEJM199902183400701 · DOI · Paper page
- K Sieradzki, 1999, The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection., N Engl J Med, 340, 517, 10.1056/NEJM199902183400704 · DOI · Paper page
- K Sieradzki, 2003, Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy., J Clin Microbiol, 41, 1687, 10.1128/JCM.41.4.1687-1693.2003 · DOI
- MM Mwangi, 2007, Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing., Proc Natl Acad Sci U S A, 104, 9451, 10.1073/pnas.0609839104 · DOI · Paper page
- K Sieradzki, 2003, Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus., J Bacteriol, 185, 7103, 10.1128/JB.185.24.7103-7110.2003 · DOI · Paper page
- BP Howden, 2006, Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia., Antimicrob Agents Chemother, 50, 3039, 10.1128/AAC.00422-06 · DOI · Paper page
- S Gardete, 2008, Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal., Microb Drug Resist, 14, 1, 10.1089/mdr.2008.0816 · DOI
- CJ Graber, 2007, Intermediate vancomycin susceptibility in a community-associated MRSA clone., Emerg Infect Dis, 13, 491, 10.3201/eid1303.060960 · DOI
- JC Hageman, 2008, Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus., Diagn Microbiol Infect Dis, 62, 440, 10.1016/j.diagmicrobio.2008.08.005 · DOI
- BL De Jonge, 1992, Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A., J Biol Chem, 267, 11248, 10.1016/S0021-9258(19)49903-1 · DOI · Paper page
- S Dubrac, 2008, A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway., Mol Microbiol, 70, 1307, 10.1111/j.1365-2958.2008.06483.x · DOI · Paper page
- S Dubrac, 2007, New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus., J Bacteriol, 189, 8257, 10.1128/JB.00645-07 · DOI · Paper page
- M Meehl, 2007, Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus., Antimicrob Agents Chemother, 51, 2679, 10.1128/AAC.00209-07 · DOI · Paper page
- Y Kato, 2010, Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR., J Antimicrob Chemother, 65, 37, 10.1093/jac/dkp394 · DOI
- JM Mei, 1997, Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis., Mol Microbiol, 26, 399, 10.1046/j.1365-2958.1997.5911966.x · DOI · Paper page
- LF Abu-Qatouseh, 2010, Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype., J Mol Med, 88, 565, 10.1007/s00109-010-0597-2 · DOI
- M Kuroda, 2000, Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method., Biochem Biophys Res Commun, 269, 485, 10.1006/bbrc.2000.2277 · DOI · Paper page
- M Kuroda, 2003, Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus., Mol Microbiol, 49, 807, 10.1046/j.1365-2958.2003.03599.x · DOI · Paper page
- S Boyle-Vavra, 2003, Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin., Antimicrob Agents Chemother, 47, 1028, 10.1128/AAC.47.3.1028-1036.2003 · DOI
- S Jordan, 2006, Regulation of LiaRS-dependent gene expression in Bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system., J Bacteriol, 188, 5153, 10.1128/JB.00310-06 · DOI · Paper page
- P Suntharalingam, 2009, The LiaFSR system regulates the cell envelope stress response in Streptococcus mutans., J Bacteriol, 191, 2973, 10.1128/JB.01563-08 · DOI
- F Fritsch, 2011, The cell envelope stress response mediated by the LiaFSRLm three-component system of Listeria monocytogenes is controlled via the phosphatase activity of the bifunctional histidine kinase LiaSLm., Microbiology, 157, 373, 10.1099/mic.0.044776-0 · DOI
- N McCallum, 2011, Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus., Antimicrob Agents Chemother, 55, 1391, 10.1128/AAC.01213-10 · DOI
- H Szurmant, 2007, YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilis., J Bacteriol, 189, 3280, 10.1128/JB.01936-06 · DOI
- A Jansen, 2007, Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus., Int J Med Microbiol, 297, 205, 10.1016/j.ijmm.2007.02.002 · DOI · Paper page
- A Reipert, 2003, Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin., Antimicrob Agents Chemother, 47, 568, 10.1128/AAC.47.2.568-576.2003 · DOI
- L Cui, 2009, Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus., Antimicrob Agents Chemother, 53, 1231, 10.1128/AAC.01173-08 · DOI
- BP Howden, 2008, Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus., Antimicrob Agents Chemother, 52, 3755, 10.1128/AAC.01613-07 · DOI
- H Tjalsma, 1999, The potential active site of the lipoprotein-specific (type II) signal peptidase of Bacillus subtilis., J Biol Chem, 274, 28191, 10.1074/jbc.274.40.28191 · DOI
- S Utaida, 2003, Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon., Microbiology, 149, 2719, 10.1099/mic.0.26426-0 · DOI · Paper page
- S Gardete, 2006, Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus., Antimicrob Agents Chemother, 50, 3424, 10.1128/AAC.00356-06 · DOI · Paper page
- JJ Iandolo, 2002, Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325., Gene, 289, 109, 10.1016/S0378-1119(02)00481-X · DOI · Paper page
- T Ohta, 2004, Nucleotide substitutions in Staphylococcus aureus strains, Mu50, Mu3, and N315., DNA Res, 11, 51, 10.1093/dnares/11.1.51 · DOI
- L Cui, 2005, DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus., Antimicrob Agents Chemother, 49, 3404, 10.1128/AAC.49.8.3404-3413.2005 · DOI
- BP Howden, 2008, Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia., BMC Microbiol, 8, 39, 10.1186/1471-2180-8-39 · DOI
- F McAleese, 2006, Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin., J Bacteriol, 188, 1120, 10.1128/JB.188.3.1120-1133.2006 · DOI · Paper page
- E Mongodin, 2003, Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin., J Bacteriol, 185, 4638, 10.1128/JB.185.15.4638-4643.2003 · DOI
- A Scherl, 2006, Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers., BMC Genomics, 7, 296, 10.1186/1471-2164-7-296 · DOI
- B Loffler, 2010, Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils., PLoS Pathog, 6, e1000715, 10.1371/journal.ppat.1000715 · DOI · Paper page
- JA Loughman, 2009, Virulence gene expression in human community-acquired Staphylococcus aureus infection., J Infect Dis, 199, 294, 10.1086/595982 · DOI
- CP Montgomery, 2008, Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia., J Infect Dis, 198, 561, 10.1086/590157 · DOI · Paper page
- AE Villaruz, 2009, A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation., J Infect Dis, 200, 724, 10.1086/604728 · DOI
- PM Dunman, 2001, Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci., J Bacteriol, 183, 7341, 10.1128/JB.183.24.7341-7353.2001 · DOI · Paper page
- B Said-Salim, 2003, Global regulation of Staphylococcus aureus genes by Rot., J Bacteriol, 185, 610, 10.1128/JB.185.2.610-619.2003 · DOI · Paper page
- K Tegmark, 2000, Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus., Mol Microbiol, 37, 398, 10.1046/j.1365-2958.2000.02003.x · DOI · Paper page
- AA Pragman, 2007, Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels., Biochemistry, 46, 314, 10.1021/bi0603266 · DOI
- AY Peleg, 2009, Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection., J Infect Dis, 199, 532, 10.1086/596511 · DOI · Paper page
- A Lalueza, 2010, Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?, J Infect Dis, 201, 311, 10.1086/649572 · DOI
- KC Horne, 2009, Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA., Antimicrob Agents Chemother, 53, 3447, 10.1128/AAC.01365-08 · DOI
- J Price, 2009, Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin., Clin Infect Dis, 48, 997, 10.1086/597359 · DOI
- DR Cameron, 2011, The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes., Clin Infect Dis, 53, 576, 10.1093/cid/cir473 · DOI
- PA Majcherczyk, 2008, Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis., Microb Pathog, 45, 408, 10.1016/j.micpath.2008.09.003 · DOI
- S Wu, 1996, A phosphoglucomutase-like gene essential for the optimal expression of methicillin resistance in Staphylococcus aureus: molecular cloning and DNA sequencing., Microb Drug Resist, 2, 277, 10.1089/mdr.1996.2.277 · DOI
- BL De Jonge, 1991, Suppression of autolysis and cell wall turnover in heterogeneous Tn 551 mutants of a methicillin-resistant Staphylococcus aureus strain., J Bacteriol, 173, 1105, 10.1128/jb.173.3.1105-1110.1991 · doi:10.1128/jb.173.3.1105-1110.1991
- EJ Lowbury, 1964, Neomycin-Resistant Staphylococcus aureus In A Burns Unit., J Hyg (Lond), 62, 221, 10.1017/S0022172400039942 · DOI
- A Tomasz, 1991, Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci., Antimicrob Agents Chemother, 35, 124, 10.1128/AAC.35.1.124 · DOI · Paper page
- DA Benson, 2010, GenBank., Nucleic Acids Res, 38, D46, 10.1093/nar/gkp1024 · DOI · Paper page
- SK Highlander, 2007, Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus., BMC Microbiol, 7, 99, 10.1186/1471-2180-7-99 · DOI · Paper page
- KE Beenken, 2004, Global gene expression in Staphylococcus aureus biofilms., J Bacteriol, 186, 4665, 10.1128/JB.186.14.4665-4684.2004 · DOI · Paper page
- ZJ Wu, 2004, A model-based background adjustment for oligonucleotide expression arrays., J Am Stat Assoc, 99, 909, 10.1198/016214504000000683 · DOI · Paper page
- G Kraemer, 1990, High-frequency transformation of Staphylococcus aureus by electroporation., Curr Microbiol, 21, 373, 10.1007/BF02199440 · DOI · Paper page
- Y Katayama, 2003, Jumping the barrier to beta-lactam resistance in Staphylococcus aureus., J Bacteriol, 185, 5465, 10.1128/JB.185.18.5465-5472.2003 · DOI
- M Chung, 2008, Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole., Antimicrob Agents Chemother, 52, 2709, 10.1128/AAC.00266-08 · DOI
- XJ Zhao, 1992, Nucleotide sequence of the Staphylococcus aureus signal peptidase II (lsp) gene., FEBS Lett, 299, 80, 10.1016/0014-5793(92)80105-P · DOI
Cited by
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Self-citationCong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
Glycopeptide antibiotics: Back to the future
Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R., & Cooper, M. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.111 · Cited by 303
Metadata
- Authors
- Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-02
- Volume
- 8
- Issue
- 2
- Pages
- e1002505
- ISSN
- 1553-7374
- Cited by
- 116
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.